Skip to content

The role of spirometry (lung function testing) in the management of chronic respiratory diseases (asthma and COPD) in general practice to improve quality of life.

The role of spirometry in managing chronic respiratory diseases in general practice to improve quality of life.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12606000378527
Acronym
SPIRO-GP study
Enrollment
726
Registered
2006-08-29
Start date
2006-03-21
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The study has been designed around the research questions a) do patients with chronic respiratory disease (asthma and/or COPD) managed with lung function testing (spirometry) through general practice have better health outcomes than patients managed without spirometry? and b) to what degree does the use of spirometry influence the way general practitioners manage patients with chronic respiratory disease? This study aims to trial lung function testing ( spirometry) as an intervention for management of asthma and chronic obstructive pulmonary disease ( COPD) in a General practice setting. The main objectives are a) to evaluate the impact of spirometry on health outcomes of patients with asthma and COPD,compared with usual care alone ( no spirometry) and b) to identify the barriers and enablers to spirometry in general practice and primary care.

Interventions

This study is a Double Blind Randomised Controlled Trial ( RCT) where practices are randomly allocated to: - Group 1 ( intervention with spirometry) For 12 months practices will receive full spirometry intervention and an interpretation of results will be notified to the treating GP -Group 2 (intervention without spirometry) For 12 months practices will receive spirometry before and after the trial, but no results will be reported to the GP

Sponsors

Monash UniversityDepartment of Epidemiology & Preventive Medicine
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Diagnosis
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
7 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

General Practices will be included if there is a commitment by the practice to participate, they agree to randomisation, are willing to recruit patients with asthma or COPD from their practices, and are willing to search their medical records database (database search training will be provided to staff if required). Eligible patients will attend a general practice on the list of divisions of general practice in Melbourne and surrounding regions. Patient inclusion criteria: attend a general practice on the list of Divisions of general Practice in Melbourne and surrounding regions, have doctor diagnosed asthma or COPD, must be able to understand English and must be able to provide written consent to participate.

Exclusion criteria

Patient exclusion criteria: are not contactable by phone, cannot speak or read English, are participating in another study involving asthma or COPD, have infrequent episodic asthma as defined by National Asthma Council (NAC) classification of childhood asthma, or other reason such as complex medical conditions eg. mental illness or cancer.

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 31, 2026